VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...

Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year for CytoDyn Inc. ("CytoDyn" or the "Company"). On February 24, 2025 ...

Advocates of TBI awareness are pushing for better care while ASX companies drop devices and drugs that are stepping up the ...

March is Traumatic Brain Injury Awareness Month, a condition that has led to permanent disability in more than 5 million ...

The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma NeuroVive, hastening its development and review. Based in Lund, NeuroVive is developing NeuroSTAT for ...

Disparities exist in access to rehabilitation following community discharge for traumatic brain injury (TBI) in olde ...

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and ...

The findings could lead to the development of new drugs with fewer side effects, ... Drug May Counteract Muscle Loss and Osteoporosis After Rapid Weight Loss Feb. 10, 2025 — Rapid weight loss ...

After hours: March 21 at 5:29:10 PM EDT Loading Chart for TBI ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

After hours: March 19 at 6:52:53 p.m. EDT ...